liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Enzymatically Triggered Peptide–Lipid Conjugation of Designed Membrane Active Peptides for Controlled Liposomal Release
Linköping University, Department of Physics, Chemistry and Biology, Biophysics and bioengineering. Linköping University, Faculty of Science & Engineering.ORCID iD: 0000-0003-4685-0505
Linköping University, Department of Physics, Chemistry and Biology, Biophysics and bioengineering. Linköping University, Faculty of Science & Engineering.
Linköping University, Department of Physics, Chemistry and Biology, Biophysics and bioengineering. Linköping University, Faculty of Science & Engineering.ORCID iD: 0000-0002-1781-1489
Linköping University, Department of Physics, Chemistry and Biology, Biophysics and bioengineering. Linköping University, Faculty of Science & Engineering.ORCID iD: 0000-0002-7001-9415
2024 (English)In: ACS Omega, E-ISSN 2470-1343, Vol. 9, no 17, p. 19613-19619Article in journal (Refereed) Published
Abstract [en]

Possibilities for controlling the release of pharmaceuticals from liposomal drug delivery systems can enhance their efficacy and reduce their side effects. Membrane-active peptides (MAPs) can be tailored to promote liposomal release when conjugated to lipid head groups using thiol-maleimide chemistry. However, the rapid oxidation of thiols hampers the optimization of such conjugation-dependent release strategies. Here, we demonstrate a de novo designed MAP modified with an enzyme-labile Cys-protection group (phenylacetamidomethyl (Phacm)) that prevents oxidation and facilitates in situ peptide lipidation. Before deprotection, the peptide lacks a defined secondary structure and does not interact with maleimide-functionalized vesicles. After deprotection of Cys using penicillin G acylase (PGA), the peptide adopts an α-helical conformation and triggers rapid release of vesicle content. Both the peptide and PGA concentrations significantly influence the conjugation process and, consequently, the release kinetics. At a PGA concentration of 5 μM the conjugation and release kinetics closely mirror those of fully reduced, unprotected peptides. We anticipate that these findings will enable further refinement of MAP conjugation and release processes, facilitating the development of sophisticated bioresponsive MAP-based liposomal drug delivery systems.

Place, publisher, year, edition, pages
American Chemical Society , 2024. Vol. 9, no 17, p. 19613-19619
National Category
Physical Chemistry
Identifiers
URN: urn:nbn:se:liu:diva-203407DOI: 10.1021/acsomega.4c01387ISI: 001242270800001PubMedID: 38708287OAI: oai:DiVA.org:liu-203407DiVA, id: diva2:1857052
Note

Funding: Swedish Research Council (VR) (grant number 2017-04475), the Swedish Cancer Foundation (grant numbers CAN 2017/430 and 21 1603 Pj 01 H), and the European Research Council (101044665 PROTECT).

Available from: 2024-05-10 Created: 2024-05-10 Last updated: 2026-10-12Bibliographically approved
In thesis
1. Design and Optimization of Membrane Active Peptides and Lipid Vesicles for Triggered Release
Open this publication in new window or tab >>Design and Optimization of Membrane Active Peptides and Lipid Vesicles for Triggered Release
2024 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Liposomes can reduce toxic side effects and improve the efficacy of drugs and several liposome-based drug formulations are approved for clinical use. The therapeutic effect is dependent on the bioavailability of the drug and a slow drug release from liposomes can reduce their efficacy. Multiple strategies have been proposed to control the release of drugs from liposomes using both external stimuli such as light, heat and ultrasound, and endogenous factors such as changes in pH or enzymatic activity. However, because of the difficulties to efficiently modulate lipid membrane permeability and the challenges to trigger drug release in the target tissue, no stimuli responsive liposomes have so far been approved. There is consequently a great need for new means to tune lipid membrane integrity for liposome cargo release to improve the development of new advanced drug delivery systems for better and safer treatment of patients.  

The aim of this thesis was to design and explore synthetic membrane active peptides for triggered release from liposomes and to expand the knowledge on how peptide-lipid conjugation strategies and lipid properties affect the membrane activity of the peptides. This work was based on two different de novo designed cationic and amphipathic, conjugation-dependent membrane active peptides (CKV4 and JR2KC). Both peptides fold and adopt α-helical structures upon conjugation to liposomes, triggering lipid membrane destabilization. Addition of cholesterol in the lipid membrane greatly enhanced the release efficiency of JR2KC due to a peptide-triggered lipid phase separation, resulting in domains with high local peptide concentrations. Additionally, both peptide surface concentrations and lipid net charge were found to be important factors for efficient release. However, when the zeta potential decreased below -75 mV, conjugation-independent release mechanisms were triggered. Liposome size was shown to only have minor effects on the release kinetics for both sets of peptides while a mixture of saturated and unsaturated lipids was beneficial for the peptide-triggered membrane destabilization, possibly due to increased propensity for lipid phase separation.  

In addition to changing lipid properties, peptide-lipid conjugation strategies proved to highly affect the release kinetics, where the Michael addition reaction between a cysteine in the peptide and maleimide-lipids was much more efficient in causing peptide-triggered membrane destabilization than strain-promoted alkyne azide cycloaddition reactions using azide-modified peptides and DBCO-functionalized lipids. However, thiols tend to oxidize under ambient conditions which complicates peptide-lipid conjugation. This was addressed by synthesizing a peptide with a cysteine modified with an enzyme labile thiol protection group. Enzymatic deprotection allowed efficient peptide-lipid conjugation, reducing the risk of peptide oxidation.  

To further find means to tailor peptide-lipid interactions, we explored the effect of a competing peptide heterodimerization process on lipid membrane destabilization. Addition of a charge complementary peptide to CKV4 resulted in heterodimerization and folding into a coiled coil, which inhibited its membrane activity. However, when the two peptides were synthesized as a single sequence, the membrane activity was altered, most likely due to the induced preorganization increasing membrane affinity. 

The results presented in this thesis provide new understandings of the complex peptide-lipid interactions that govern peptide-induced release from liposomes and will facilitate further optimization in peptide design for the future development of advanced liposome-based drug delivery systems. 

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2024. p. 88
Series
Linköping Studies in Science and Technology. Dissertations, ISSN 0345-7524 ; 2389
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:liu:diva-203408 (URN)10.3384/9789180756648 (DOI)9789180756631 (ISBN)9789180756648 (ISBN)
Public defence
2024-06-12, Planck, F-Building, Campus Valla, Linköping, 09:15 (English)
Opponent
Supervisors
Available from: 2024-05-10 Created: 2024-05-10 Last updated: 2025-02-20Bibliographically approved

Open Access in DiVA

fulltext(2412 kB)282 downloads
File information
File name FULLTEXT01.pdfFile size 2412 kBChecksum SHA-512
248b9badef1d2b2fa5ef94f33826d5d0554c13427e7d7448a5d2600e538c77fecbe94ec50880a8599afbcf2599ac6b2032e38f36a2a074c4b1d9590d3e82083c
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Iversen, AlexandraUtterström, JohannaSelegård, RobertAili, Daniel

Search in DiVA

By author/editor
Iversen, AlexandraUtterström, JohannaSelegård, RobertAili, Daniel
By organisation
Biophysics and bioengineeringFaculty of Science & Engineering
In the same journal
ACS Omega
Physical Chemistry

Search outside of DiVA

GoogleGoogle Scholar
Total: 283 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 890 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf